internationalbadassactivists.org
FDA kicks back Acer’s rare disease drug, demands new test—shares in freefall | FierceBiotech
Acer Therapeutics’ stock plummeted more than 78% premarket this morning on news that the FDA had rejected approval of its drug Edsivo (celiprolol). Source: FDA kicks back Acer’s rare disease …